FindTrial
Sign In

Valsartan 160 mg

DRUG5 trials

Sponsors

Novartis, Assistance Publique - Hôpitaux de Paris, Novartis Pharmaceuticals, University of Alabama at Birmingham

Conditions

Cardiovascular DiseasesChronic Heart FailureDiabetes MellitusEnergy ExpenditureEssential HypertensionHealthyHypertensionInsulin Sensitivity/Resistance

Phase 1

Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-Blocker
CompletedNCT00310778
Assistance Publique - Hôpitaux de ParisHealthy
Start: 2006-03-31End: 2007-03-31Updated: 2008-09-22

Phase 2

A Study of Valsartan Administered Once Daily Versus Twice Daily, in Patients With Stable, Chronic Heart Failure
CompletedNCT00294086
NovartisChronic Heart Failure
Start: 2005-12-31End: 2007-01-31Target: 160Updated: 2011-06-08
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
RecruitingNCT04055428
University of Alabama at BirminghamCardiovascular Diseases, Diabetes Mellitus, Energy Expenditure +4
Start: 2020-08-15End: 2027-05-31Target: 200Updated: 2025-07-03

Phase 3

Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension
CompletedNCT00413413
Novartis PharmaceuticalsHypertension
Start: 2007-01-31End: 2007-11-30Updated: 2011-04-28
Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension
CompletedNCT01001572
NovartisEssential Hypertension
Start: 2009-09-30End: 2010-05-31Updated: 2011-05-24